New CRISPR tool opens up more of the genome for editing
Enzyme can target almost half of the genome’s “ZIP codes” and could enable editing of many more disease-specific mutations.
Enzyme can target almost half of the genome’s “ZIP codes” and could enable editing of many more disease-specific mutations.
Global Microbiome Conservancy research reveals surprising new insights into human gut microbiomes.
Biological engineers design RNA circuits that enable precise control over the dose of therapeutic protein a patient receives.
New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.
McGovern Institute scientist is recognized with award for outstanding and creative achievements made in the life and medical sciences.
Researchers identify an essential protein that helps enzymes relax overtwisted DNA so each strand can be copied during cell division.
Biologists discover that the environment surrounding a cell plays an integral role in its ability to accurately segregate its chromosomes.
Graduate student Kelsey Moore uses genetic and fossil evidence to study the first stages of evolution on our planet.
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
A new daughter helped Alejandra Falla PhD ’18 gain perspective on life — and her tiny MIT regalia stole the show at Commencement.
Biophysicist will investigate the biology of RNA aggregation.
Scientists leverage one step, unbiased method to characterize the binding preferences of more than 70 human RNA-binding proteins.
Scientists identify the first known network consisting of three types of regulatory RNAs.
Study reveals why people with the APOE4 gene have higher risk of the disease.